SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹33 Cr | ₹22 Cr | ₹20 Cr | ₹18 Cr | ₹9.72 Cr |
What is the latest Sundry Debtors ratio of SHREE GANESH REMEDIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹33 Cr |
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹20 Cr |
| Mar2020 | ₹18 Cr |
| Mar2019 | ₹9.72 Cr |
How is Sundry Debtors of SHREE GANESH REMEDIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹33 Cr | 46.23 | |
| Mar2025 | ₹22 Cr | 9.53 | |
| Mar2024 | ₹20 Cr | 14.31 | |
| Mar2020 | ₹18 Cr | 82.97 | |
| Mar2019 | ₹9.72 Cr | - | |
Compare Sundry Debtors of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹869.3 Cr | -3.5% | 30.9% | 24.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -3.5% |
30.9% |
24.5% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses